3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
7
Terminated
2
Withdrawn
1
Unknown
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Lymphoma
14
Leukemia
14
Breast Neoplasms
9
Lymphoma, Large B-Cell, Diffuse
7
Osteosarcoma
5
Gestational Trophoblastic Disease
4
Central Nervous System Neoplasms
4
Meningeal Carcinomatosis
3
Lymphoma, Extranodal NK-T-Cell
3
Astrocytoma
3
Squamous Cell Carcinoma of Head and Neck
2
Recurrence
2
Oligodendroglioma
2
Myelodysplastic Syndromes
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Leukemia, T-Cell
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Graft vs Host Disease
2
Drug-Related Side Effects and Adverse Reactions
2
Dendritic Cell Sarcoma, Interdigitating
2
Choroid Plexus Neoplasms
2
Burkitt Lymphoma
2
Water Intoxication
1
Thrombocythemia, Essential
1
Subcutaneous panniculitis-like T-cell lymphoma
1
Spinal Cord Neoplasms
1
Interventions
Radiosurgery
12
Temozolomide
10
Radiotherapy
10
Magnetic Resonance Spectroscopy
7
Erlotinib Hydrochloride
6
Bevacizumab
6
Surgical Procedures, Operative
5
Pemetrexed
5
Gefitinib
5
Drug Therapy
5
Carboplatin
5
pyrotinib
4
icotinib
4
aumolertinib
4
Trastuzumab
3
Spermine Synthase
3
Radiation
3
Lomustine
3
Etoposide
3
Dexmedetomidine
3
Chlorotoxin
3
Carmustine
3
osimertinib
2
camrelizumab
2
apatinib
2
Tyrosine Kinase Inhibitors
2
Thiotepa
2
Surveys and Questionnaires
2
Sevoflurane
2
Propofol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Brain Neoplasms
×
Methotrexate
×
Clear all
NCT03613181
2023-04-24
ANGLeD
Angiochem Inc
Phase 3
Unknown
150 enrolled